Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fresenius Noninvasive Blood Pressure Validation - Three Phase Study PR 2020-377

NCT04573595 is registered in ClinicalTrials.gov with Fresenius Medical Care North America as lead sponsor.

NCT NCT04573595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04573595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fresenius Noninvasive Blood Pressure Validation - Three Phase Study PR 2020-377
Lead sponsor
Fresenius Medical Care North America
Phase
Not applicable
Overall status
Completed
Start date
September 17, 2020
Completion date
December 4, 2020
Enrollment
159 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure